Tag: Dr. Pablo J. Cagnoni
Rubius announces 3 new patents for cellular-therapy program
PROVIDENCE – Rubius Therapeutics, a Cambridge, Mass.-based biotech firm that develops and genetically engineers red blood cells for use in medications for rare diseases,...
Rubius appoints Holles to board, Whitehead as SVP, chief quality officer
PROVIDENCE – Rubius Therapeutics Inc. has appointed Natalie Holles to its board of directors and Greg Whitehead as senior vice president and chief quality...
- Featured Event -
